breachesMedicinesAustraliaThe article reports the breach of the code of conduct regarding the promotions and advertising of medicines in Australia. It informs that the Medicines Australia Code of Conduct regulates the promotion of prescription products which are made by pharmaceutical companies. A table ...
AustraliaThe article presents information on the Medicines Australia Code of Conduct which guides the promotion of prescription products by pharmaceutical companies in Australia. It informs that the Code of Conduct Committee manages the breaches made by these companies and takes them to court for ...
The article reports on the concerns raised by CHOICE and other consumer advocate groups over the lack of transparency of transaction between pharmaceutical firms and health care professionals in industry grou...
Medicines Australia Code of Conduct reviewdoi:10.1177/1039856214550564fNoneAustralasian Psychiatry
The article offers some examples of breach of Medicines Australia Code of Conduct. According to the Code of Conduct Committee, offering to give 25 cents per prescription to a research institute is a breach of the Code. It mentions that selective citation of data, misleading graphical presentations...
Medicines Australia Code of Conduct (Edition 16), section 9.12 [cited 2010 Feb 28]: Available from URL: http://www.medicinesaustralia.com.au/pages/images/ Code-of-Conduct-Edition-16.pdfMedicines Australia Code of Conduct, Medicines Australia, 2011. http://medicinesaustralia.com.au/code-of-...
AustraliaA chart is presented which show breaches of guidelines in Medicines Australia Code of Conduct performed by pharmaceutical companies from July 2013-June 2014 including AstraZeneca, Boehringer Ingelheim, and Novartis.EBSCO_AspAustralian Prescriber...
A chart is presented that lists the breaches made on the Medicines Australia Code of Conduct as of July 2009 to June 2010 including the promotional activity of Allergan Inc. for Botox or botulinum toxin, the advertorial of Boehringer Ingelheim Ltd. for Mobic or meloxicam, and the patient ...
Unfortunately, learning to communicate with the public has not historically been part of a scientist’s training and is not a skill that comes naturally to all scientists, nor one that is a prerequisite for researchers [21,22]. Concerns regarding the time required to conduct science communication...
providing pharmacy personnel an opportunity to engage with the public about their CM use. CMs are currently non-scheduled products in Australia. This review aimed to summarize the literature reporting the potential effect on pharmacies if scheduling of CMs was adopted, using codeine as an example. ...